Vidasat-M tablets combine Vildagliptin and Metformin Hydrochloride to manage type 2 diabetes. Vildagliptin is a DPP-4 inhibitor that increases insulin secretion and decreases glucagon levels, while Metformin reduces glucose production in the liver and improves insulin sensitivity. This combination effectively controls blood sugar levels. Dosage should be directed by a healthcare provider to ensure optimal diabetes management and minimize side effects.Available in PCD pharma franchise and Third Party manufacturing in saturn formulations